Interestingly, when investigating the potential effect of long-term treatment with levodopa on the circadian rhythm deregulation in the 6-hydroxydopamine PD mouse model, Li et al. reported that L-dopa treatment further downregulated BMAL1 expression in the SCN and the striatum [58]. Here, BMAL1 is linked to Parkinson disease.